|1.||Zhen, Yong-Su: 23 articles (12/2014 - 06/2005)|
|2.||Li, Yi: 11 articles (01/2015 - 06/2005)|
|3.||Li, Liang: 9 articles (01/2015 - 08/2005)|
|4.||Zhang, Sheng-Hua: 9 articles (12/2014 - 06/2007)|
|5.||Shang, Yue: 7 articles (01/2015 - 06/2005)|
|6.||Shang, Bo-Yang: 7 articles (01/2014 - 07/2005)|
|7.||Zhen, Yong-su: 7 articles (01/2013 - 04/2002)|
|8.||Shao, Rong-Guang: 6 articles (02/2014 - 09/2004)|
|9.||Wang, Zhen: 5 articles (01/2015 - 06/2003)|
|10.||Liu, Xiu-Jun: 5 articles (12/2014 - 06/2005)|
|1.||Hepatocellular Carcinoma (Hepatoma)
07/14/2005 - "Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule."
07/14/2005 - "To study the in vitro and in vivo antitumor effect of lidamycin (LDM) on hepatoma and the active moiety of its molecule. "
09/15/2004 - "The aim of this study was to investigate the possible link between centrosome dynamics and lidamycin-induced mitotic cell death in human hepatoma BEL-7402 cells. "
03/01/2001 - "To study the features of cell death induced by the anticancer antibiotic lidamycin (LDM) in human hepatoma BEL-7402 cells. "
06/01/2009 - "Increased FOXO3a, SOD-1 and SOD-2 expression and transient phosphorylation of ERK were detected after exposure of human hepatoma BEL-7402 cells to 0.5 nmol/L lidamycin. "
01/01/2015 - "Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor."
11/01/2011 - "This study is to investigate inhibitory effects of lidamycin (LDM) on the proliferation of HERG K+ channel highly expressing cancer cells and its synergy with anticancer drugs. "
01/01/2015 - "Lidamycin (LDM), a potent antitumor antibiotic, demonstrates good antitumor efficacy in various tumor types, both in vitro and in vivo. "
01/01/2015 - "These findings reveal the potential mechanism of lidamycin on tumor initiating cells and the benefit for further clinical evaluation."
01/01/2015 - "In brief, these results suggest that lidamycin suppressed Huh7 tumor initiating cells via GSK3β/β-catenin pathway. "
07/01/2013 - "Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells."
07/01/2009 - "In the present study, the effects of lidamycin (LDM), a member of the enediyne antibiotic family, on two human multiple myeloma (MM) cell lines, U266 and SKO-007, were evaluated. "
07/01/2009 - "To investigate the effects of lidamycin (LDM) on a mouse myeloma cell line (SP2/0) and human multiple myeloma cell lines (U266 and SKO-007), and provide the basis for the use of LDM in cancer therapy. "
07/01/2009 - "Enediyne lidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase."
11/20/2012 - "The results showed that energized fusion protein (Arg)(9)-LDP-AE was more effective than lidamycin and would be a promising candidate for glioma therapy. "
07/07/2009 - "Conclusion Lidamycin can inhibit vasculogenic mimicry and promote apoptosis of glioma cells. "
07/07/2009 - "Tube formation assay was performed to estimate the inhibitory effects of lidamycin upon vasculogenic mimicry in C6 and U87 glioma cells. "
07/07/2009 - "To evaluate the in vitro effects of lidamycin upon vasculogenic mimicry and apoptosis induction in glioma cells. "
07/07/2009 - "[Inhibitory effect of lidamycin upon vasculogenic mimicry and its induction of apoptosis in glioma cells]."
|5.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2014 - "To investigate the potentiation of antitumor efficacy of lidamycin (LDM), an enediyne agent by the Hsp90 inhibitor geldanamycin (GDM), and possible mechanisms, we have determined effects on ovarian cancer SKOV- 3, hepatoma Bel-7402 and HepG2 cells by MTT assay, apoptosis assay, and cell cycle analysis. "
|1.||Factor VII (Proconvertin)
|4.||DNA (Deoxyribonucleic Acid)
|7.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|9.||Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
|10.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)